Viriom

About:

Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.

Website: http://viriom.com/

Twitter/X: viriominc

Top Investors: Torrey Pines Investment, Skolkovo Foundation, ChemRar Ltd, Pharmstandard, MIT RF

Description:

Viriom Inc. is a development and commercial stage biotech company developing novel and affordable medicines against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 3 and commercial stage lead compounds (Elpida/elsulfavirine and VM1500A) from Hoffmann-La Roche and has developed proprietary drug candidates VM2500, VM3500 LAI formulations and combinations with cell, vaccine and antibody drugs for treatment, prophylaxis and cure of HIV. Viriom makes a breakthrough in treating, preventing and curing HIV and chronic HBV infections worldwide.